Related Experiment Videos
In the pipeline: encorafenib and binimetinib in BRAF-mutated melanoma
1Harvard Medical School, Boston, Massachusetts.
Clinical Advances in Hematology & Oncology : H&O
|October 18, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Exploratory Analysis of Biomarkers and Treatment Outcomes from the COLUMBUS Study in BRAF V600E/K-Mutant Advanced or Metastatic Melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Redefining second-line treatment strategy, sequencing, and real-world implementation in relapsed/refractory multiple myeloma: insights from the 31st Annual Congress of the European Hematology Association.
Clinical advances in hematology & oncology : H&O·2026
Neoadjuvant therapies in high-risk localized prostate cancer: past, present, and future.
Clinical advances in hematology & oncology : H&O·2026
Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations.
Clinical advances in hematology & oncology : H&O·2026
Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.
Clinical advances in hematology & oncology : H&O·2026